Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1586189.
- Also identified by PMC identifier 1590513.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A newborn is described in whom the use of a central venous line was complicated by septicaemia and by intracardiac thrombus formation with tricuspid valve insufficiency and heart failure. Besides antibiotics, treatment consisted of tissue type plasminogen activator (tPA) for three days. This treatment resulted in the disappearance of the thrombus and the tricuspid insufficiency. No adverse effects were noted. Treatment with tPA should be considered in intracardiac thrombus formation with rapidly progressive heart failure in the neonate.
Medical subject headings
- Heart Failure
- Thrombolytic Therapy
- Thrombosis
- Tissue Plasminogen Activator
- Tricuspid Valve Insufficiency